186895-55-6

Basic information

• Product Name: (3R,4R,5E,7S)-3,5,7-trimethyl-9-phenyl-1,5-nonadien-4-ol
• Synonyms: (3R,4R,5E,7S)-3,5,7-trimethyl-9-phenyl-1,5-nonadien-4-ol
• CAS NO: 186895-55-6
• Molecular Weight: 258.404
• Mol File: 186895-55-6.mol

Chemical Properties

• CAS DataBase Reference: (3R,4R,5E,7S)-3,5,7-trimethyl-9-phenyl-1,5-nonadien-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,4R,5E,7S)-3,5,7-trimethyl-9-phenyl-1,5-nonadien-4-ol(186895-55-6)
• EPA Substance Registry System: (3R,4R,5E,7S)-3,5,7-trimethyl-9-phenyl-1,5-nonadien-4-ol(186895-55-6)

Safety Data

• Hazardous Substances Data: 186895-55-6(Hazardous Substances Data)

Upstream product

• 186895-52-3 ethyl (2E,4S)-2,4-dimethyl-6-phenyl-2-hexenoate 
• 186895-53-4 (2E,4S)-2,4-dimethyl-6-phenyl-2-hexen-ol 
• 186895-72-7 (S)-2-methyl-4-phenyl-1-butyraldehyde 
• 3023-61-8 (-)-(S)-2-methyl-4-phenylbutan-1-ol 
• 768-56-9 4-Phenylbut-1-ene 
• 770711-54-1 (S)-1,1-dibromo-3-methyl-5-phenyl-1-pentene 
• 770711-55-2 (S)-4-methyl-6-phenyl-2-hexyne 
• 624-64-6 trans-2-Butene 
• 186895-54-5 (2E,4S)-2,4-dimethyl-6-phenyl-2-hexen-1-al 

Downstream Products

• 186895-56-7 (3R,4R,5E,7S)-4-(tert-butyldimethylsilyloxy)-3,5,7-trimethyl-9-phenyl-1,5-nonadiene 
• 770711-51-8 (4R,5R,6E,8S)-4,6,8-trimethyl-5-(t-butyldimethylsilyloxy)-10-phenyl-6-decen-2-yne 
• 770711-58-5 (3R,4R,5E,7S)-1,1-dibromo-3,5,7-trimethyl-4-(t-butyldimethylsilyloxy)-9-phenyl-1,5-nonadiene 
• 770711-49-4 (3E,5R,6R,7E,9S)-3,5,7,9-tetramethyl-6-(t-butyldimethylsilyloxy)-11-phenyl-3,7-undecadien-1-yne 
• 770711-57-4 (3E,5R,6R,7E,9S)-1,1-dibromo-3,5,7,9-tetramethyl-6-(t-butyldimethylsilyloxy)-11-phenyl-1,3,7-undecatriene 
• 770711-60-9 (3E,5R,6R,7E,9S)-1-trimethylsilyl-3,5,7,9-tetramethyl-6-(t-butyldimethylsilyloxy)-11-phenyl-3,7-undecadien-1-yne 
• 770711-59-6 (3Z,5R,6R,7E,9S)-1-trimethylsilyl-3-bromo-5,7,9-trimethyl-6-(t-butyldimethylsilyloxy)-11-phenyl-3,7-undecadien-1-yne 
• 770711-62-1 (2E,4E,8E,10E,14E)-(12R,13R,16S)-13-Hydroxy-2,10,12,14,16-pentamethyl-18-phenyl-octadeca-2,4,8,10,14-pentaen-6-ynoic acid 
• 770711-61-0 ethyl (2E,4E,8E,10E,12R,13R,14E,16S)-2,10,12,14,16-pentamethyl-13-hydroxy-18-phenyl-2,4,8,10,14-octadecapentaen-6-ynoate 
• 770711-50-7 ethyl (2E,4E,8E,10E,12R,13R,14E,16S)-2,10,12,14,16-pentamethyl-13-(t-butyldimethylsilyloxy)-18-phenyl-2,4,8,10,14-octadecapentaen-6-ynoate 
• 186895-62-5 (1E,3E,5R,6R,7E,9S)-1-iodo-3,5,7,9-tetramethyl-6-(t-butyldimethylsilyloxy)-11-phenyl-1,3,7-undecatriene 
• 186895-57-8 (2RS,3R,4R,5E,7S)-4-(tert-butyldimethylsilyloxy)-1,2-dihydroxy-3,5,7-trimethyl-9-phenyl-5-nonene 
• 186895-58-9 (2S,3R,4E,6S)-3-(tert-butyldimethylsilyloxy)-2,4,6-trimethyl-8-phenyl-4-octanal 
• 186895-61-4 (2E,4R,5R,6E,8S)-5-(tert-butyldimethylsilyloxy)-10-phenyl-2,4,6,8-tetramethyl-2,6-decadienal 

Relevant articles and documents

Efficient and selective synthesis of 6,7-dehydrostipiamide via Zr-catalyzed asymmetric carboalumination and Pd-catalyzed cross-coupling of organozincs

(Chemical Equation Presented) 6,7-Dehydrostipiamide has been synthesized in 23% yield in 15 steps in the longest linear sequence through the application of the Zr-catalyzed asymmetric carboalumination and the Pd-catalyzed organozinc cross-coupling in addi

Total synthesis of stipiamide and designed polyenes as new agents for the reversal of multidrug resistance

The synthesis of (-)-stipiamide (1) is reported together with the designed enynes 2 (6,7-dehydrostipiamide) and 3 that are now shown to reverse the multidrug resistance (MDR) of human breast cancer cells (MCF-7adrR). Stipiamide was assembled using a Still